| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 29, 2022 |
The biggest medtech stock gainers, losers in 2022 | (From Ishant Mishra on Unsplash) In another roller coaster year for medtech, these are the companies that saw their stock rise and fall the most drastically.
The MassDevice MedTech 100 Index, which includes stocks of the world’s largest med... |
| Dec 20, 2022 |
Embecta stock slides on mixed Q4 results | Embecta (Nasdaq:EMBC) shares dipped before the market opened today on fourth-quarter results that came in mixed compared to the consensus forecast.
EMBC shares fell more than 12% to $29.73 apiece in morning trading. MassDevice‘s MedTech 100... |
| Dec 19, 2022 |
Staar Surgical CEO Caren Mason retires, replacement named | Caren Mason [Image courtesy of MDMA]Staar Surgical (Nasdaq:STAA) announced today that President and CEO Caren Mason intends to retire at the end of the year.
Mason plans to retire on Dec. 31, 2022 from Staar, a creator of implantable lenses... |
| Dec 15, 2022 |
Siemens Healthineers, GE HealthCare reportedly express interest in Medtronic units | According to reports, Siemens Healthineers and GE HealthCare registered interest in acquiring business units from Medtronic (NYSE:MDT).
Bloomberg first reported the interest from the two companies in two units Medtronic plans to spinoff. Th... |
| Nov 29, 2022 |
Boston Scientific to acquire Apollo Endosurgery for more than $600M | Boston Scientific (NYSE:BSX) today announced it entered a definitive agreement to acquire Apollo Endosurgery (NSDQ:APEN) for more than $600 million.
The Marlborough, Massachusetts-based company will acquire the endoluminal surgical device m... |
| Nov 22, 2022 |
Medtronic reduces guidance amid slower procedures and supply recovery | Medtronic (NYSE:MDT) today reported second-quarter financial results that beat Wall Street expectations on earnings but missed on revenue.
On top of the mixed results, the world’s largest medical device company reduced its guidance for the ... |
| Nov 16, 2022 |
Alcon stock rises on Q3 EPS beat | Alcon (NYSE:ALC) shares ticked up this morning on third-quarter results that came in ahead of the consensus earnings forecast.
Shares of ALC were up more than 4% at $66.47 apiece by early afternoon trading today. MassDevice’s MedTech 100 In... |
| Nov 15, 2022 |
Conmed pulls 2022 guidance due to software implementation | Conmed (NYSE:CNMD) announced today that it is withdrawing its full-year outlook over problems implementing software at its main distribution facility.
Largo, Florida-based Conmed last month issued its guidance with a reduction from previous... |
| Nov 15, 2022 |
Pear Therapeutics posts mixed bag Q3, cuts 22% of workforce | Pear Therapeutics (Nasdaq:PEAR) stock is down today — a day after it reported mixed third-quarter results.
The Boston-based prescription digital therapeutic (PDT) developer also announced a large set of layoffs yesterday evening. The new la... |
| Nov 14, 2022 |
Dentsply Sirona stock dips on Q3 misses, lowered guidance | Dentsply Sirona (Nasdaq:XRAY) shares took a slight hit today on third-quarter results that came up shy of the consensus forecast.
The Charlotte, North Carolina-based dental equipment and supplies maker posted losses of $1.1 billion in the q... |
| Nov 10, 2022 |
Stereotaxis stock up on new orders, progress on next-gen robot | Stereotaxis’ headquarters in St. Louis include an operating room with a Genesis RMN system for demonstration and training purposes. [Image courtesy of Stereotaxis]Stereotaxis (NYSE:STXS) today reported third-quarter results that missed on r... |
| Nov 10, 2022 |
ZimVie sticks by its full-year guidance | ZimVie (Nasdaq:ZIMV) reported mixed third-quarter results but reaffirmed its full-year guidance.
Many medical device companies have been tightening or reducing guidance amid the present macroeconomic headwinds. With ZimVie announcing yester... |
| Nov 10, 2022 |
NuVasive reports mixed Q3 results, reduces guidance | NuVasive (Nasdaq:NUVA) reported third-quarter results that beat on EPS but missed on revenue, reducing its guidance amid macroeconomic headwinds.
Investors reacted to yesterday evening’s news by sending NUVA shares down more than 1% to 36.8... |
| Nov 10, 2022 |
Steris sticks by EPS guidance amid additional currency headwinds | Steris (NYSE: STE) reported mixed third-quarter results, but it held the line on EPS guidance amid additional foreign currency headwinds.
The provider of sterilization services and other infection prevention tech lost $315.2 million, or $3.... |
| Nov 9, 2022 |
Outset Medical skyrockets on Q3 revenue beat, raises full-year guidance | Outset Medical (Nasdaq:OM) this week posted third-quarter results that were in line with earnings estimates and beat the revenue consensus on Wall Street.
The San Jose, California-based home hemodialysis device maker reported net losses of ... |
| Nov 9, 2022 |
Surgalign plans layoffs | Surgalign (Nasdaq:SRGA) today announced a board-approved corporate restructuring plan that includes layoffs.
The Deerfield, Illinois–based spine surgery tech company did not disclose how many jobs may be cut amid the planned streamlining an... |
| Nov 9, 2022 |
Masimo stock down on supply chain, economic headwinds | Masimo (Nasdaq: MASI) reported third-quarter results that beat the consensus forecast on Wall Street — but it held down its Q4 guidance.
“We delivered strong results in the third quarter, with revenue and earnings exceeding expectations. Ou... |
| Nov 8, 2022 |
Vicarious Surgical posts larger-than-expected losses in Q3 | Vicarious Surgical (NYSE:RBOT) posted third-quarter results today that fell short of the consensus forecast on Wall Street.
The Waltham, Massachusetts-based robotics technology developer reported a net loss of $24.7 million, or -$0.20 per s... |
| Nov 8, 2022 |
Medtronic RDN trial fails to beat hypertension drugs; data submitted for FDA review | Medtronic’s Symplicity Spyral renal denervation catheter [Image courtesy of Medtronic]Medtronic (NYSE:MDT) said its Symplicity Spyral renal denervation (RDN) system for treating hypertension failed to outperform blood pressure drugs in the ... |
| Nov 7, 2022 |
Rewalk Robotics seeks reimbursement wins | Rewalk Robotics (Nasdaq: RWLK) today reported its third-quarter revenues were half what they were a year before, with losses widening.
However, the robotic exoskeletons company is seeking to advance its technology through reimbursement wins... |
| Nov 4, 2022 |
Cardinal Health beats The Street in Q1 — but takes a hit on PPE | Cardinal Health (NYSE: CAH) today reported first-quarter results that beat the consensus forecast on Wall Street, sticking by its full-year EPS guidance.
The Dublin, Ohio–based pharma and medtech giant earned $110 million, or 40¢ per share,... |
| Nov 1, 2022 |
Johnson & Johnson to acquire Abiomed for $16.6B | Johnson & Johnson (NYSE:JNJ) announced today that it agreed to acquire Abiomed (Nasdaq:ABMD) for approximately $16.6 billion.
Under the agreement, Johnson & Johnson intends to acquire through tender offer all outstanding Abiomed sha... |
| Nov 1, 2022 |
Abiomed stock skyrockets on Q3 results ahead of Johnson & Johnson acquisition | Abiomed (Nasdaq:ABMD) shares soared before hours on third-quarter results and the news of its acquisition by Johnson & Johnson (NYSE:JNJ).
Johnson & Johnson announced this morning that it agreed to buy Abiomed for $16.6 billion.
Sha... |
| Oct 27, 2022 |
Merit Medical rises on Street-beating Q3, raised guidance | Merit Medical Systems (Nasdaq:MMSI) shares are up today — a day after it reported Q3 results that topped the consensus forecast.
The South Jordan, Utah-based disposable medical device maker announced yesterday evening that it posted profits... |
| Oct 27, 2022 |
Dexcom stock rises on Q3 results following G7 international rollout | Dexcom (Nasdaq:DXCM) shares ticked up after hours today on third-quarter results that came in ahead of the consensus forecast.
DXCM shares rose 6.7% at $108 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includ... |
| Oct 27, 2022 |
Teleflex profits drop 48% in Q3 | Teleflex (NYSE:TFX) today posted third-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates.
The Wayne, Pennsylvania–based maker of critical care and surgical products reported profits of $101.9 milli... |
| Oct 27, 2022 |
Conmed stock slides on Q3 revenue miss, slashed EPS guidance | Conmed (NYSE:CNMD) shares took a hit today on third-quarter results that missed the consensus revenue forecast.
CNMD shares fell 7.8% to $77.15 apiece in morning trading. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s... |
| Oct 27, 2022 |
Baxter records $3.1B impairment over Hillrom acquisition | Baxter (NYSE:BAX) today posted third-quarter results that were in line with estimates on Wall Street, but it lowered its outlook for the remainder of the year amid macroeconomic headwinds.
The Deerfield, Ill.–based company — maker of renal ... |
| Oct 27, 2022 |
Integer Q3 results mixed amid supply chain challenges | Integer Holdings (NYSE:ITGR) today reported third-quarter results that beat The Street on earnings but missed on revenue amid continued supply chain challenges.
The Plano, Texas–based medtech contract manufacturing giant had already warned ... |
| Oct 27, 2022 |
Align Technology stock sinks on Q3 sales, EPS misses | Align Technology (Nasdaq:ALGN) shares took a massive hit today — a day after it reported Q3 results well short of the consensus forecast.
ALGN shares fell 15.9% to $186.35 apiece in mid-morning trading. MassDevice‘s MedTech 100 Index — whic... |
| Oct 26, 2022 |
Boston Scientific reports mixed Q3 results amid challenging economic environment | Boston Scientific (NYSE: BSX) today reported third-quarter revenue that beat the consensus forecast on Wall Street, but it missed by a penny on earnings.
The Marlborough, Massachusetts–based interventional medical devices giant also reduced... |
| Oct 26, 2022 |
Integra Lifesciences rises on Street-beating Q3 results | Integra Lifesciences (NSDQ:IART) today posted third-quarter results that beat the overall consensus on Wall Street.
The surgical and medical instrument maker reported profits of $49.9 million, or 60¢ per share, on sales of $385.2 million fo... |
| Oct 25, 2022 |
3M cuts its 2022 guidance amid uncertain economic times | 3M (NYSE: MMM) today posted mixed Q3 results and cut its guidance amid a strong dollar and uncertain economic environment.
Meanwhile, CEO Mike Roman said in a news release that the company has started the work to successfully spin out its H... |
| Oct 25, 2022 |
GE posts mixed-bag Q3 results as GE HealthCare spinoff remains on track | GE (NYSE: GE) this week posted third-quarter results that beat the revenue consensus on Wall Street but missed on earnings.
GE HealthCare spinoff plans remain on track for an early January 2023 completion.
The Boston-based company reported ... |
| Oct 24, 2022 |
Philips is cutting its workforce by 4,000 | Royal Philips (NYSE: PHG, AEX: PHIA) is launching a significant restructuring amid its serious CPAP recall, supply chain woes and other macroeconomic challenges.
The Dutch medtech giant announced today that it would cut its workforce by rou... |
| Oct 24, 2022 |
Medtronic plans spinoff of patient monitoring, respiratory intervention businesses | Medtronic (NYSE: MDT) today announced its intention to pursue a separation of the company’s Patient Monitoring and Respiratory Interventions businesses, part of the company’s Medical Surgical portfolio.
The separation is the next step in th... |
| Oct 19, 2022 |
Abbott beats The Street in Q3 on stronger U.S. medical device sales | The sensor for the next-generation FreeStyle Libre 3 CGM is the same size as two U.S. pennies stacked together. [Image courtesy of Abbott]Abbott (NYSE: ABT) today reported third-quarter results that beat the consensus forecast on Wall Stree... |
| Oct 18, 2022 |
Intuitive beats The Street in Q3, increases da Vinci surgical robot base | Intuitive Surgical (Nasdaq:ISRG) shares received a boost on third-quarter results that topped the consensus forecast.
Shares of ISRG skyrocketed after hours. They rose 11.4% to $215.85 apiece after the market closed. MassDevice’s MedTech 10... |
| Oct 18, 2022 |
Johnson & Johnson beats The Street in Q3, MedTech sales rise | Johnson & Johnson (NYSE:JNJ) today reported third-quarter results that topped the consensus forecast, with MedTech business sales up more than 2%.
The New Brunswick, New Jersey-based company posted profits of $4.5 billion, or $1.68 per ... |
| Oct 13, 2022 |
FDA approves Nevro HFX iQ spinal cord stimulation | Senza HFX iQ spinal cord stimulation (SCS) system [Image from Nevro]Nevro (NYSE:NVR) announced that the FDA approved its Senza HFX iQ spinal cord stimulation (SCS) system.
Redwood City, California-based Nevro designed Senza HFX iQ to use ar... |
| Oct 12, 2022 |
Owens & Minor announces executive leadership changes, lowers 2022 guidance | Andrew Long
Owens & Minor (NYSE:OMI) announced today that it appointed Andrew Long as EVP and CEO for its products & healthcare services segment.
Its stock also took a major hit today on lower 2022 guidance amid continued macroecono... |
| Oct 12, 2022 |
Philips says Q3 sales down 5% amid supply chain problems | Royal Philips (NYSE: PHG) saw its stock fall more than 11% in value today after reporting that supply chain challenges were worse than expected during Q3 2022.
The result is that the Dutch medtech giant now expects third quarter sales to be... |
| Oct 11, 2022 |
Orthofix, SeaSpine plan all-stock merger to create global spine and orthopedic company | Orthofix (Nasdaq:OFIX) and SeaSpine (Nasdaq:SPNE) today announced a definitive agreement to combine companies in an all-stock merger of equals.
Under the terms of the agreement, SeaSpine shareholders will receive 0.4163 shares of Orthofix c... |
| Sep 21, 2022 | iRhythm wants to be a $1 billion a year company in 5 years | iRhythm’s Zio XT cardiac monitor. [Image from iRhythm]iRhythm Technologies (Nasdaq:IRTC) officials think their company’s wearable heart monitoring tech could serve millions more patients, tripling company revenue to more than $1 billion by ... |
| Sep 14, 2022 | J&J announces $5B share repurchase | Johnson & Johnson (NYSE: JNJ) announced today that its board has authorized a $5 billion repurchase of its common stock.
“The last few years have demonstrated the resilience of Johnson & Johnson. With continued confidence in our bus... |
| Sep 14, 2022 | Baxter is reportedly considering a sale of its kidney care businesses | Baxter (NYSE:BAX) is reportedly weighing the divestiture of its renal care services and hemodialysis business.
According to a Bloomberg report, the company is considering splitting with its kidney care businesses as part of a refocusing eff... |
| Sep 12, 2022 | Investors sue Medtronic over insulin pump problems | An FDA warning letter for Medtronic’s Diabetes business cast uncertainty over approval of the company’s next-gen MiniMed 780G system. [Image from Medtronic]Add a potential class action shareholder lawsuit to the challenges Medtronic (NYSE: ... |
| Aug 23, 2022 | Medtronic sticks by guidance amid unpredictable times | Medtronic (NYSE:MDT) today reported first-quarter results that beat The Street by a whisker, sticking by its full-year guidance amid a tough economic environment.
The medtech giant’s management has increasingly faced questions from analysts... |
| Aug 16, 2022 | Philips names Roy Jakobs as CEO amid ventilator, CPAP recalls | The plan is for Roy Jakobs to become Philips’s president and CEO, effective October 15. [Image courtesy of Royal Philips]Philips‘ (NYSE:PHG) today announced that it plans for Roy Jakobs to succeed Frans van Houten as president and CEO, effe... |
| Aug 15, 2022 | Outset Medical wins national VA contract | Outset Medical (Nasdaq:OM) announced today that it has won a national contract with the U.S. Department of Veterans Affairs to sell its Tablo hemodialysis system into the department’s 106 VA hospitals.
San Jose, California–based Outset alre... |
| Aug 10, 2022 | Surgalign settles on OEM business sale, posts Q2 earnings miss | Surgalign (Nasdaq:SRGA) shares are down today on the news of its second-quarter financial results and a global settlement agreement.
Shares of SRGA were down 8.3% at $5.50 apiece before the market opened this morning. They sank even further... |
| Aug 10, 2022 | Alcon lowers its 2022 forecast amid strong dollar | Alcon (SIX/NYSE:ALC) posted Street-beating second quarter results but lowered its 2022 guidance amid a challenging macroeconomic environment.
The Geneva-based eye care tech giant announced yesterday evening that it earned $148 million, or 3... |
| Aug 5, 2022 | Globus Medical rebounds in Q2, sticks by guidance | Globus Medical (NYSE:GMED) reported second-quarter results that beat the overall consensus on Wall Street.
The Audubon, Pennsylvania-based musculoskeletal device company reported profits of $54.6 million, or 53¢ per share, on sales of $263.... |
| Aug 5, 2022 | Alphatec stock is up on 36% sales growth in Q2 | Alphatec (NSDQ:ATEC) shares rose today on second-quarter results that were mixed compared to the consensus forecast.
The Carlsbad, California–based spine surgery device company posted losses of $37.3 million, or 36¢ per share, on sales of $... |
| Aug 3, 2022 | Zimmer Biomet speeds up investments in NeuroOne | NeuroOne Medical Technologies (Nasdaq: NMTC) announced today that it will receive an accelerated $3.5 million milestone payment from Zimmer Biomet.
The milestone payment is related to Eden Prairie, Minnesota–based NeuroOne’s Evo sEEG electr... |
| Aug 3, 2022 | Siemens Healthineers sales down nearly 6% in Q3, but it sticks with outlook | Siemens Healthineers (ETR:SHL) shares are on the decline today upon the release of the company’s third-quarter financial results.
Shares of SHL were down 0.9% at $24.93 per share in mid-afternoon trading today. MassDevice’s MedTech 100 Inde... |
| Aug 3, 2022 | Butterfly Network rises on Q2 results, will reduce workforce to extend cash runway | The Butterfly Network IQ+ system [Image courtesy of Butterfly Network]Butterfly Network (NYSE:BFLY) shares are up on second-quarter results that beat the consensus forecast, with the company announcing plans to reduce a tenth of its workfor... |
| Aug 2, 2022 | Fresenius Medical Care reports labor issues, inflation challenges as it cuts 2022 outlook | Fresenius Medical Care (NYSE:FMS) shares are up slightly on second-quarter results that topped the consensus forecast.
The Bad Homburg v. d. Höhe, Germany-based dialysis company posted profits of $150.3 million (€147 million), or 51¢ (€0.50... |
| Aug 2, 2022 | Henry Schein misses on Q2 sales amid declining demand for COVID-19 tests | Henry Schein (Nasdaq:HSIC) shares are down today on second-quarter sales that missed the Wall Street consensus forecast amid declining COVID-19 test demand and foreign exchange headwinds.
The Melville, New York–based company posted profits ... |
| Aug 2, 2022 | Axonics expects 40% revenue growth this year | Axonics (Nasdaq:AXNX) shares are on the rise today on second-quarter results that came in ahead of the consensus forecast amid a successful TV advertising campaign.
The Irvine, California–based sacral neuromodulation technology developer po... |
| Aug 1, 2022 | Outset Medical stock skyrockets on resumed Tablo shipments | [Image from Outset Medical]Outset Medical (Nasdaq:OM) shares are up big today on the news that people needing dialysis will once again be able to receive Tablo systems for home use.
The news of the shipment hold’s end was enough to countera... |
| Jul 29, 2022 | CVRx stock up on Street-beating Q2 sales, raised guidance | CVRx (Nasdaq:CVRX) shares were up this morning on second-quarter results that beat the consensus revenue forecast.
The Minneapolis-based neuromodulation technology developer posted losses of $11.1 million, or 54¢ per share, on sales of just... |
| Jul 28, 2022 | Baxter misses on revenue in Q2, cuts outlook amid ‘macroeconomic headwinds’ | Baxter (NYSE:BAX) shares are down today on mixed second-quarter results, with the medtech giant reducing its full-year outlook amid supply chain challenges and inflationary pressures.
BAX shares were down more than 10% to $59.66 apiece in m... |
| Jul 28, 2022 | Integer boosts 2022 revenue projections, cuts earnings outlook | Integer (NYSE:ITGR) posted second-quarter results today that beat the overall consensus forecast on Wall Street.
The Plano, Texas–based medical device outsource manufacturer reported profits of $20.8 million, or 62¢ per share, on sales of $... |
| Jul 28, 2022 | Smith+Nephew stock dives on Q2 results, lowered 2022 trading margin guidance | Smith+Nephew (NYSE:SNN) shares took a hit today as the company revealed in its second-quarter earnings that it lowered its 2022 forecast.
SNN shares were down more than 11% to $25.85 apiece in morning trading today on the New York Stock Exc... |
| Jul 28, 2022 | Conmed stock dips on lowered guidance despite Street-beating Q2 | Conmed (NYSE:CNMD) shares are down today on lowered 2022 guidance, even as its Q2 results beat Wall Street expectations.
The Largo, Florida–based company posted losses of $168.3 million, or $5.65 per share, on sales of $277.2 million for th... |
| Jul 27, 2022 | Stryker ups its revenue growth projections for 2022 | Stryker (NYSE:SYK) shares are up today — a day after it boosted revenue growth projections while reporting Q2 results that were shy of the consensus forecast.
Shares of SYK were up more than 1% to $207.68 apiece by midday trading today. Mas... |
| Jul 27, 2022 | Integra dips despite Street-beating Q2, plans to divest traditional wound care business | Integra Lifesciences (NSDQ:IART) shares were down today despite second-quarter results that came in ahead of the consensus forecast.
The surgical and medical instrument maker also announced that it inked an agreement in May to sell its trad... |
| Jul 26, 2022 | Q2 Supply chain, COVID-19 issues lead to slightly lowered expectations for GE HealthCare | The new logo for the stand-alone GE HealthCare company, expected to spin off early next year. [Image courtesy of GE Healthcare]GE (NYSE:GE) shares were up on second-quarter results that came in ahead of the consensus forecast on Wall Street... |
| Jul 26, 2022 | 3M Health Care to become standalone company | 3M (NYSE: MMM) announced today that it plans to spin off its Health Care business by the end of 2023.
The new Health Care business will be a roughly $9-billion-a-year company focusing on wound care, oral care, healthcare IT and biopharma fi... |
| Jul 21, 2022 | Acutus Medical names new CEO, reports preliminary Q2 revenues | [Image from Acutus]Acutus Medical (Nasdaq:AFIB) announced today that it has officially appointed David Roman as its new president and CEO, taking the “interim” out of his title.
Roman’s appointment to the positions, as well as to a membersh... |
| Jul 21, 2022 | Danaher rises on Street-beating Q2 | Danaher (NYSE:DHR) shares got a boost today on second-quarter results that came in well ahead of the consensus forecast.
Shares of DHR were up 7.7% at $275.61 per share in mid-morning trading today. MassDevice’s MedTech 100 Index — which in... |
| Jul 8, 2022 | iRhythm stock up on positive news out of CMS | iRhythm Technologies (Nasdaq:IRTC) stock soared today on positive reimbursement news out of CMS as the agency makes 2023 fee schedule proposals.
Truist analysts yesterday evening pointed to CMS proposing a national coverage determination (N... |
| Jun 14, 2022 | OrthoPediatrics buys Pega Medical for up to $33M | The Fassier-Duval Telescopic Intramedullary System is a self-extending rod meant to prevent or stabilize fractures or correct deformity of long bones while growth occurs. [Image courtesy of Pega Medical]OrthoPediatrics announced today that ... |
| Jun 14, 2022 | Outset Medical stock down on shipment hold news | Outset Medical (Nasdaq: OM) stock lost about a third of its value today — a day after the company said it was holding shipments of its Tablo hemodialysis system for home use.
OM shares were down more than 34% to $13.46 apiece by the close o... |
| May 27, 2022 | Needham & Co. downgrades Medtronic, Zimmer Biomet shares | [Image from Unsplash]Needham & Co. Senior Research Analyst Mike Matson today downgraded his rating of Medtronic (NYSE:MDT) and Zimmer Biomet (NYSE:ZBH) shares to Hold, while Boston Scientific (NYSE:BSX) got an upgrade to Buy.
MDT shares... |
| May 27, 2022 | Will Johnson & Johnson buy Boston Scientific? | Needham & Co. analyst Mike Matson today upgraded his rating of Boston Scientific (NYSE:BSX) shares to Buy, partly because he thinks it’s an acquisition target for Johnson & Johnson (NYSE:JNJ).
Said Matson: “If JNJ decides to acquire... |
| May 26, 2022 | Medtronic stock down on Q4 earnings miss | Medtronic (NYSE:MDT) shares are down today on fourth-quarter results that missed the consensus forecast.
Shares of MDT were down more than 4% to $100.56 apiece in morning trading today. MassDevice‘s MedTech 100 Index, which includes stocks ... |
| May 6, 2022 | Axonics raises 2022 sales guidance on Street-beating Q1 | Axonics Modulation Technologies (Nasdaq:AXNX) reported first-quarter financial results that topped analysts’ consensus forecast.
The Irvine, California–based sacral neuromodulation technology developer posted losses of $22.7 million, or 50¢... |
| May 6, 2022 | Orthofix beats The Street in Q1, reaffirms 2022 guidance | Orthofix (Nasdaq:OFIX) recorded first-quarter financial results that came in ahead of the consensus forecast on Wall Street.
The Lewisville, Texas-based orthopedic implant company posted losses of $4.5 million, or 22¢ per share, on sales of... |
| May 5, 2022 | Butterfly shares dip on Q1 losses as revenues miss analysts’ expectations | The Butterfly Network IQ+ system [Image courtesy of Butterfly Network]Butterfly Network (NYSE:BFLY) shares took a hit today on first-quarter results that missed the consensus sales forecast.
The Burlington, Massachusetts–based company poste... |
| May 5, 2022 | Staar Surgical rises on Street-beating Q1, Evo lens shipments remain ‘robust’ | [Image from Staar Surgical]Staar Surgical (Nasdaq:STAA) shares got a boost this morning on first-quarter results that topped the consensus forecast.
STAA shares were up 11% at $70.91 per share as the market opened today. MassDevice’s MedTec... |
| May 5, 2022 | Tandem stock down after Q1 EPS miss | Image from Tandem Diabetes
Tandem Diabetes Care (Nasdaq:TNDM) shares are down today, a day after first-quarter results that were mixed compared to the consensus forecast.
The San Diego-based automated insulin delivery technology developer p... |
| May 5, 2022 | Conmed beats The Street in Q1, announces $145M deal to acquire In2Bones | Conmed (NSDQ:CNMD) announced that it will acquire In2Bones Global for more than $145 million after it posted first-quarter results that beat the overall consensus on Wall Street.
The Largo, Florida–based minimally invasive medical device co... |
| May 4, 2022 | TransMedics skyrockets on Q1 results, increased 2022 guidance | TransMedics (Nasdaq:TMDX) shares got a massive boost today on first-quarter sales that were 64% higher than the consensus forecast.
TMDX shares were up more than 30% at $28.44 apiece by midday trading today. MassDevice’s MedTech 100 Index —... |
| May 4, 2022 | Owens & Minor ticks up on Street-beating Q1 | Owens & Minor (NYSE:OMI) shares are on the rise today on first-quarter results that beat the consensus forecast.
The Richmond, Virginia-based company posted profits of $29.3 million, or 52¢ per share, on sales of $2.4 billion for the th... |
| May 4, 2022 | Masimo beats Street in Q1 — even with ‘unexpected’ supply chain issues | Masimo (Nasdaq:MASI) stock is up today, a day after first-quarter results that topped the consensus forecast.
MASI shares were up more than 5% at $124.05 apiece by the late morning. MassDevice’s MedTech 100 Index — which includes stocks of ... |
| May 3, 2022 | Zimmer Biomet rises on Street-beating Q1, raised guidance | Zimmer Biomet (NYSE:ZBH) shares ticked up this morning on first-quarter results ahead of the consensus forecast, with ZB upping its 2022 forecast.
The Warsaw, Indiana–based company posted profits of $14.2 million, or 7¢ per share, on sales ... |
| May 2, 2022 | Masimo announces limited consumer release of W1 health watch | Former professional tennis player Tommy Haas said the Masimo W1 health watch provides a convenient way to continuously track vitals. [Image courtesy of Masimo]Masimo (Nasdaq: MASI) today announced that it will make its much-anticipated W1 h... |
| Apr 28, 2022 | Dexcom dips after hours on Q1 EPS miss | Dexcom (Nasdaq:DXCM) shares took a hit after hours today on first-quarter results that fell short of the consensus earnings forecast.
DXCM shares were down 6.2% at $387.61 per share after the market closed. MassDevice’s MedTech 100 Index — ... |
| Apr 28, 2022 | Teleflex stock down despite Street-beating Q1 | Teleflex (NYSE:TFX) shares slided today, even as the company reported first-quarter results that came in ahead of the consensus forecast.
The Wayne, Pennsylvanis–based critical care and surgical tech company posted profits of $77.1 million,... |
| Apr 28, 2022 | Baxter posts Street-beating Q1 results, cites ‘positive momentum’ from Hillrom acquisition | Baxter (NYSE:BAX) this week posted first-quarter results that beat the overall consensus on Wall Street.
The Deerfield, Illinois-based maker of products to kidney disease — and a host of other chronic and acute medical conditions — reported... |
| Apr 27, 2022 | Boston Scientific beats The Street in Q1 | Boston Scientific (NYSE:BSX) shares were up this morning on first-quarter results that topped the consensus forecast.
The Marlborough, Massachusetts–based interventional medtech maker posted profits of $97 million, or 7¢ per share, on sales... |
| Apr 27, 2022 | Integra Lifesciences beats The Street in Q1 | Integra Lifesciences (NSDQ:IART) posted first-quarter results that beat the overall consensus on Wall Street.
The Princeton, N.J.-based surgical and medical instrument company reported profits of $32.9 million, or 39¢ per share, on sales of... |
| Apr 27, 2022 | Acutus Medical sells left-heart access portfolio to Medtronic in $50M deal | Acutus Medical (NSDQ:AFIB) today announced that it has entered a definitive agreement to sell its left-heart access portfolio to Medtronic (NYSE:MDT) for $50 million.
Medtronic will make an upfront cash payment to Princeton, N.J.–based Acut... |
| Apr 26, 2022 | 3M Health Care leads the way in Street-beating Q1 | 3M (NYSE: MMM) today reported first-quarter results that beat the consensus forecast on Wall Street, with Health Care turning in the best performance among the industrial conglomerate’s businesses.
Maplewood, Minnesota–based 3M earned nearl... |
| Apr 26, 2022 | GE beats The Street in Q1, stock falls as supply chain issues impact guidance | GE (NYSE:GE) shares took a hit today despite first-quarter results ahead of the consensus forecast.
GE shares were down more than 11% at $79.44 apiece by afternoon trading today. MassDevice‘s MedTech 100 Index — which includes stocks of the... |
| Apr 26, 2022 | Edwards Lifesciences shares fall on Street-beating Q1 results | Edwards Lifesciences (NYSE: EW) posted first-quarter results today that beat the consensus forecast on Wall Street.
It also reaffirmed its outlook for the rest of the year, with CEO Michael Mussallem saying, “We are hopeful the worst of the... |
| Apr 26, 2022 | NeuroMetrix revenues rise in Q1 | The Quell wearable pain relief device [Image courtesy of NeuroMetrix]NeuroMetrix (Nasdaq:NURO) shares dipped today on first-quarter results that saw losses despite year-over-year revenue growth.
The Woburn, Massachusetts–based company poste... |